Search for: "Commonwealth v. Labelle" Results 1 - 20 of 138
Sorted by Relevance | Sort by Date
RSS Subscribe: 20 results | 100 results
13 Aug 2009, 4:07 am
Back in January, we put up a short post noting the filing of a petition for extraordinary ("King's Bench") review in the case of Commonwealth v. [read post]
16 Nov 2010, 6:00 am
This issue was litigated and decided on January 4, 2010 in the Western District of Kentucky in a case called Commonwealth Brands, Inc. v. [read post]
9 Jul 2011, 10:34 pm by David Jacobson
In Australian Competition and Consumer Commission v Singtel Optus Pty Ltd (No 4) [2011] FCA 761 Optus was ordered to pay to the Commonwealth a pecuniary penalty of $5.26 million for misleading advertisements (Optus 1 was previously discussed here). [read post]
22 Aug 2014, 9:22 am
April 24, 2014) (distributor of generic drugs had no power to change labeling unilaterally); Stevens v. [read post]
11 Aug 2011, 7:58 am by info@thomasjhenrylaw.com
“Despite the narrow FDA-approved indications for Risperdal, Janssen developed and executed marketing and sales plans designed to promote Risperdal for uses that had not been established to be safe and/or effective and to minimize the many risks associated with Risperdal's use,” Commonwealth of Massachusetts v. [read post]
3 Jan 2011, 9:45 pm by Law Lady
Health Care Reform: VIRGINIA FEDERAL JUDGE DERAILS PART OF HEALTH CARE REFORM LAW, Commonwealth v. [read post]
9 Nov 2009, 10:24 am
Horan issued a November 5, 2009 Opinion and Order in the post-Koken case of Baptiste v. [read post]